Practice audit of wet AMD referrals

Warburton, Trevor; Parker, Susan
May 2013
Optometry Today;5/3/2013, Vol. 53 Issue 9, p38
The article explores referrals for wet age-related macular degeneration (AMD) in Stockport, England. Considered an urgent condition, wet AMD requires direct referral to a treatment center. The first standard to consider is whether the referrals were correct, specifically questioning the diagnosis of wet AMD. Symptoms of wet AMD include recent visual loss, distortion or a blurred patch in the vision or findings of macular hemorrhage. Other referral standards are discussed.


Related Articles

  • A Fresh Look at Drug Delivery. Ambati, Jayakrishna; Adamis, Anthony P.; Regillo, Carl; T-Cunningham Jr, Emmett // Review of Ophthalmology;Aug2001, Vol. 8 Issue 8, p74 

    Focuses on the development of drug therapy and delivery systems for retinal choroidal neovascularization in age-related macular degeneration and diabetic retinopathy. Causes of vision loss in diabetic retinopathy; Development of anti-angiogenic agents; Role of prinomastat in the remodeling of...

  • Eye Care.  // Life Extension;May2003 Supplement, Vol. 9, p106 

    Examines the association of age-related macular degeneration (AMD) with blindness in the U.S. Clinical manifestation of cataract; Diagnostic criteria of glaucoma; Factors influencing vision and cataract development.

  • Self-test for macular degeneration.  // Consumer Reports on Health;Dec2000, Vol. 12 Issue 12, p2 

    Presents a self-test for macular degeneration. Consideration of age-related macular degeneration as the leading cause of blindness for people over 50 years old; Importance of regular eye monitoring for early detection of the condition; Instructions of the test.

  • How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom? Owen, C.G.; Fletcher, A.E.; Donoghue, M.; Rudnicka, A.R. // British Journal of Ophthalmology;Mar2003, Vol. 87 Issue 3, p312 

    Aims: To predict the burden of blindness, partial sight, and visual impairment (binocular visual acuity 6/18 or less) due to late stage age related macular degeneration (AMD) in the ageing population of the United Kingdom. Methods: A systematic review, followed by a request for data, was used to...

  • PROTECT YOUR VISION NOW.  // Body Bulletin;Feb2003, Vol. 4 Issue 2, p3 

    Discusses the leading causes of blindness in the U.S. Contribution of macular degeneration in damaging the retina; Pressure caused by glaucoma in the eyes; Damage caused by diabetic eye disease on the tiny blood vessels in the eyes of people with high blood sugar.

  • Mean platelet volume as a marker of branch retinal vein occlusion may be influenced by many factors. Aksoy, Yakup; Eyi, Yusuf Emrah; Kar, Taner; Sevinc, Mehmet Koray; Rishi, Ekta; Gopal, Lingam; Rishi, Pukhraj; Sengupta, Sabyasachi; Sharma, Tarun // Indian Journal of Ophthalmology;Nov2013, Vol. 61 Issue 11, p686 

    A response from the authors of the article "Submacular hemorrhage: A study amongst Indian eyes" in a 2012 issue is presented.

  • Spontaneous activity of opsin apoprotein is a cause of Leber congenital amaurosis. Woodruff, Michael L.; Zhongyan Wang; Hae Yun Chung; Redmond, T.Michael; Fain, Gordon L.; Lem, Janis // Nature Genetics;Oct2003, Vol. 35 Issue 2, p158 

    Mutations in Rpe65 disrupt synthesis of the opsin chromophore ligand 11-cis-retinal and cause Leber congenital amaurosis (LCA), a severe, early-onset retinal dystrophy. To test whether light-independent signaling by unliganded opsin causes the degeneration, we used Rpe65-null mice, a model of...

  • Helping blind people see. Kren, Lawrence // Machine Design;10/24/2002, Vol. 74 Issue 20, p50 

    Discusses the use of a microelectromechanical system array to help blind people see. Background on the incidence of macular degeneration in the U.S.; Features of the electrode array; Problem concerning the stimulation of retinal nerves.

  • Radiation therapy for `wet' type macular degeneration shows promise in early trials. Skolnick, Andrew A. // JAMA: Journal of the American Medical Association;3/5/97, Vol. 277 Issue 9, p698 

    Reports that early clinical trials of an experimental treatment for the leading cause of blindness have yielded encouraging results. Use of low-dose external beam radiation to halt the proliferation of blood vessels beneath the retinas of patients with age-related macular degeneration of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics